Navigation Links
UCI receives $5M from Edwards Lifesciences

Irvine, Calif., September 12, 2007 - UC Irvines Henry Samueli School of Engineering has received a $5 million gift from Edwards Lifesciences Corporation to establish a center focused on researching and developing the next generation of cardiovascular devices.

The Edwards Lifesciences Center for Advanced Cardiovascular Technology will promote interaction and collaboration among students, faculty members and experts by incorporating both undergraduate and graduate programs related to heart and vascular diseases. The programs will be directed by UCIs Department of Biomedical Engineering, and will involve a variety of other disciplines, including students from the Integrated Nanosystems Research Facility, the California Institute for Telecommunications and Information Technology, the Donald Bren School of Information and Computer Sciences, the Beckman Laser Institute, and UCIs Schools of Medicine, Physical Sciences, and Biological Sciences.

The center also will provide a training environment for hosting prominent experts in the field of cardiovascular technology. It will be located in Engineering 3, a new building on the UCI campus scheduled for completion in August 2009.

A national search is under way for a director, who will be charged with establishing a strategic plan and forming a leadership council to determine the centers specific direction.

Our goal is to create an interdisciplinary facility that encourages students, faculty, researchers and visiting scholars to collaborate and exchange new ideas to drive the development of cardiovascular advancements and devices, said Steven C. George, M.D., William J. Link chair and professor of the Department of Biomedical Engineering, who is spearheading the centers development. The Edwards Lifesciences Center will thoroughly examine the integration of numerous disciplines, such as materials science, computer science, advanced imaging and microfabrication, or the manufacturing of devices with precision at levels much smaller than a millimeter, which all have the potential to lead to implantable devices that can help treat cardiovascular disease.

The Department of Biomedical Engineering, which was established in 2002 and is comprised of 16 faculty members, focuses on education, training, research and technology in areas like manufacturing miniature devices, biomedical lasers, developing computer simulations, and designing artificial tissues in the area of tissue engineering to further advance biomedical technology.

We are pleased to closely collaborate with Edwards Lifesciences, an international leader in cardiovascular technology, to develop a center that combines exceptional faculty, resources and tools to advance this evolving field, said Nicolaos G. Alexopoulos, dean of The Henry Samueli School of Engineering. UC Irvine is located in one of the largest medical device company clusters in the world, which I believe uniquely positions us to address this critical health care area and initiate a world class center.

Irvine-based Edwards Lifesciences, which develops products and technologies to treat advanced cardiovascular disease, is granting the multiyear gift through the Edwards Lifesciences Fund. The fund was established to support advancements in knowledge and improvements in quality of life to help those affected by cardiovascular disease, particularly in the communities where the companys employees live and work.

We are proud to partner with a neighbor that is as accomplished and committed to excellence as UC Irvine to establish a center devoted to transformational cardiovascular technology research, said Michael A. Mussallem, Edwards Lifesciences' chairman and CEO. This grant is a testament to our dedication to providing innovative solutions for people fighting cardiovascular disease, as well as our commitment to strengthening the communities in which we live and work.


Contact: Jason Mednick
University of California - Irvine

Related biology news :

1. DuPonts first biologically derived polymer receives global recognition
2. OneWorld Health drug receives Orphan designation from U.S. and European regulatory agencies
3. Research on antibiotics receives historical recognition
4. Anthrax test, developed by army and CDC, receives FDA approval
5. Research team receives $7.5 million to study cassava
Post Your Comments:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/26/2016)... Research and Markets has announced ... 2016-2020"  report to their offering.  , ,     (Logo: ... analysts forecast the global multimodal biometrics market to ... period 2016-2020.  Multimodal biometrics is being ... the healthcare, BFSI, transportation, automotive, and government for ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology: